Early Stage Glycosylation Biomarkers in Alzheimer’s Disease

Alzheimer’s disease (AD) is of great cause for concern in our ageing population, which currently lacks diagnostic tools to permit accurate and timely diagnosis for affected individuals. The development of such tools could enable therapeutic interventions earlier in the disease course and thus potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Regan, Patricia, McClean, Paula L., Smyth, Thomas, Doherty, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789538/
https://www.ncbi.nlm.nih.gov/pubmed/31484367
http://dx.doi.org/10.3390/medicines6030092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789538/
https://www.ncbi.nlm.nih.gov/pubmed/31484367
http://dx.doi.org/10.3390/medicines6030092

Ejemplares similares